About AccuVein
AccuVein is a Healthcare company based in Huntington (United States) founded in 2006. Vein visualization systems are developed and marketed for medical imaging. AccuVein has raised $60.46 million across 10 funding rounds from investors including Bessemer Venture Partners, NIH and Horizon Tech Finance. The company has 65 employees. Its chief executive, as recorded, is Chris Hutchison. Its website accuvein.com draws about 13 thousand monthly visits. AccuVein offers products and services including Vein Visualization System, AV500, and Accessories. Its focus areas include Life Sciences, Hospital Equipment, Critical Care and Vein Visualization. Its legal entity is AccuVein, Inc.
Company details
AccuVein is engaged in the development, manufacturing, and marketing of a range of medical imaging solutions. Its flagship product vein viewing system is the worlds first handheld, non-contact vein illumination solution that allows mapping of peripheral veins on the skins surface and improves venipuncture. It also offers hands-free accessories such as wheeled stand, a portable hands-free solution that consists of a pole clamp and a flexible arm.
- Headquarters Huntington, United States
- Employees 65
- SectorsHealthcare
- Email••••••••
- Website accuvein.com
- Social LinkedIn X Facebook
- Legal Name Accuvein, Inc.
- Total Equity Funding$60.46M (USD)
in 10 rounds
- Latest Funding Round$5.31M (USD), Series B
Feb 2023
- InvestorsBessemer Venture Partners
& 3 more
- Employee Count65
Products & Services of AccuVein
AccuVein offers a comprehensive portfolio of products and services, including Vein Visualization System, AV500, and Accessories.
Uses near-infrared technology to display veins for accurate insertions.
Device for vein assessment to improve clinical decision-making.
Components that enhance vein visualization system functionality.
Funding Insights of AccuVein
AccuVein has successfully raised a total of $60.46M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $5.31 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60.46M
- Total Rounds 10
- Last Round Series B — $5.31M
- Investors Count 4
All 10 funding rounds of AccuVein with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $5.31M | Series B | – | – | – |
| Sep 2020 | $13.79M | Series B | – | – | – |
| May 2020 | $2.55M | Series B | – | – | – |
| Nov 2019 | $2M | Series B | – | – | – |
| Feb 2018 | $8M | Series B | – | – | – |
| Jan 2018 | $2.9M | Series B | – | – | – |
| Dec 2016 | $2.46M | Series B | – | – | – |
| Feb 2014 | $8M | Debt – Venture | – | – | |
| Oct 2011 | $23.46M | Series B | – | Bessemer Venture Partners | |
| Nov 2010 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in AccuVein
AccuVein has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, NIH and Horizon Tech Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | bvp.com | Redwood City, United States | |
Private equity investments in healthcare companies are managed. | 1997 | mvm.com | London, United Kingdom | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for AccuVein
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AccuVein
14 people are tracked at AccuVein (12 in leadership, 2 in team); the tracked headcount is 65.
| Name | Role | Group |
|---|---|---|
Chris Hutchison | President & CEO | Leadership |
Jeff Schou | VP, International Business Development | Leadership |
Korehisa Oyama | Director, Asian Business Development | Leadership |
Robert Jaquith | Director of Commercial Operations | Leadership |
Brad Washburne | COO | Leadership |
Scott George | Vice President National Hospitals | Leadership |
Fred Wood | Chief Scientist | Leadership |
Pete Marshall | VP, Research & Development | Leadership |
Scott Pleau | Chief Operating Officer | Leadership |
Kevin McArdle | CFO | Leadership |
Philip Spiegel | Chief Commercial Officer | Leadership |
Sue Vallejo | Senior Director, Human Resources & Corporate Compliance | Leadership |
Kelly Loder, SHRM-CP | Business Operations Manager | Team |
Julie Colaianni | Senior Accountant | Team |
Complete people profiles for AccuVein
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AccuVein
3 dated milestones of AccuVein across 17 years, from founding to its latest funding, stage changes and deals.
- Founded AccuVein is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $5.3M.
Web traffic of AccuVein
The website of AccuVein (accuvein.com) receives about 13.1K visits a month.
- Monthly visits13.1K
▲ 22.4% vs previous month
Websites whose visitors overlap most with AccuVein. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| infiniummedical.com | 100% | 30.3K | #1,015,374 | View details | |
| christiemed.com | 96% | 4.2K | #4,300,582 | View details | |
| veinlite.com | 96% | #1,129,878 | View details | ||
mumbai.all.biz | mumbai.all.biz | 81% | – | ||
| medicalsearch.com.au | 78% | 47.4K | #715,154 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for AccuVein
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as AccuVein (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accuvein
Complete news archive for AccuVein
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuVein
AccuVein was founded in 2006 and raised its 1st funding round 4 years after it was founded.
AccuVein is headquartered in Huntington, United States.
Chris Hutchison is the CEO of AccuVein, as recorded in our data.
AccuVein is a funded company, having raised a total of $60.46M across 10 funding rounds to date.
AccuVein has 65 employees.
AccuVein is engaged in the development, manufacturing, and marketing of a range of medical imaging solutions. Its flagship product vein viewing system is the worlds first handheld, non-contact vein illumination solution that allows mapping of peripheral veins on the skins surface and improves venipuncture. It also offers hands-free accessories such as wheeled stand, a portable hands-free solution that consists of a pole clamp and a flexible arm.
AccuVein offers Vein Visualization System, AV500, and Accessories.
AccuVein has 4 investors. Key investors include Bessemer Venture Partners, NIH, Horizon Tech Finance, and MVM Partners.
AccuVein operates through Accuvein, Inc..